Trial Profile
Hepatic arterial embolisation with irinotecan versus systemic FOLFIRI in patients with liver metastases from colorectal cancer
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 13 Jun 2012
Price :
$35
*
At a glance
- Drugs Irinotecan (Primary) ; Fluorouracil; Folinic acid; Irinotecan
- Indications Colorectal cancer; Liver metastases
- Focus Biomarker; Therapeutic Use
- 21 Jan 2012 Results presented at the 2012 Gastrointestinal Cancers Symposium.
- 12 Oct 2010 Updated 24-month results (n=74) presented at the 35th Congress of the European Society for Medical Oncology
- 27 Jun 2009 Interim 18-month primary endpoint results presented at the 11th World Congress on Gastrointestinal Cancer